Celularity (CELUW) Change in Taxes (2019 - 2020)
Celularity (CELUW) reported Change in Taxes of -$81701.0 for Q4 2020, down 164.51% year-over-year from $126642.0 in Q1 2020, and down 261.78% quarter-over-quarter from -$22583.0 in Q3 2020.
Celularity (CELUW) Change in Taxes (2019 - 2020) Analysis & Trends
Celularity (CELUW) has 2 years of Change in Taxes data on file, last reported at -$81701.0 in Q4 2020.
- Change in Taxes for Q4 2020 came in at -$81701.0, down 164.51% year-over-year; the trailing twelve-month figure through Dec 2020 was -$18883.0 (changed N/A YoY), and the FY2020 annual result was -$18883.0, down 200.0% from the prior year.
- Change in Taxes slipped to -$81701.0 in Q4 2020 per CELUW's latest filing, from -$22583.0 in the prior quarter.
- Over five years, Change in Taxes peaked at $126642.0 in Q4 2019 and troughed at -$224650.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Celularity | - | - | -3.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -81,701.00 |
| Dec 31, 2020 | -81,701.00 |
| Sep 30, 2020 | -22,583.00 |
| Sep 30, 2020 | -22,583.00 |
| Jun 30, 2020 | 42,192.00 |
| Jun 30, 2020 | 42,192.00 |
| Mar 31, 2020 | 43,209.00 |
| Mar 31, 2020 | 43,209.00 |
| Dec 31, 2019 | 126,642.00 |
| Dec 31, 2019 | 126,642.00 |
| Sep 30, 2019 | -224,650.00 |
| Sep 30, 2019 | -224,650.00 |